1. Home
  2. ASPI vs TNYA Comparison

ASPI vs TNYA Comparison

Compare ASPI & TNYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ASP Isotopes Inc.

ASPI

ASP Isotopes Inc.

HOLD

Current Price

$5.26

Market Cap

637.1M

Sector

Industrials

ML Signal

HOLD

Logo Tenaya Therapeutics Inc.

TNYA

Tenaya Therapeutics Inc.

HOLD

Current Price

$0.81

Market Cap

169.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASPI
TNYA
Founded
2021
2016
Country
United States
United States
Employees
N/A
70
Industry
Major Chemicals
Medicinal Chemicals and Botanical Products
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
637.1M
169.9M
IPO Year
2022
2021

Fundamental Metrics

Financial Performance
Metric
ASPI
TNYA
Price
$5.26
$0.81
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
3
Target Price
$12.00
$5.33
AVG Volume (30 Days)
3.7M
4.9M
Earning Date
04-10-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
54.96
EPS
N/A
N/A
Revenue
$23,849,000.00
N/A
Revenue This Year
$68.41
N/A
Revenue Next Year
$126.69
N/A
P/E Ratio
N/A
N/A
Revenue Growth
475.48
N/A
52 Week Low
$3.92
$0.39
52 Week High
$14.49
$2.35

Technical Indicators

Market Signals
Indicator
ASPI
TNYA
Relative Strength Index (RSI) 48.23 49.77
Support Level $5.13 $0.65
Resistance Level $5.88 $0.82
Average True Range (ATR) 0.42 0.09
MACD -0.07 -0.01
Stochastic Oscillator 25.81 25.77

Price Performance

Historical Comparison
ASPI
TNYA

About ASPI ASP Isotopes Inc.

ASP Isotopes Inc is a materials company focused on producing and commercializing enriched isotopes for the nuclear medicine, healthcare, green energy, and quantum computing industries. Using proprietary technology-the Aerodynamic Separation Process (ASP)-the company enriches isotopes in South Africa, targeting high-value, low-volume markets to reduce reliance on foreign supply chains. Geographically, the company operates in South Africa, Hong Kong and United States generating key revenue from the Hong Kong region.

About TNYA Tenaya Therapeutics Inc.

Tenaya Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of therapies targeting the underlying mechanisms of heart disease. It is developing therapies for rare genetic disorders as well as for more prevalent heart conditions through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine. The company's clinical-stage gene therapy candidates include TN-201 and TN-401. It operates in one operating segment, which is the business of discovering and developing potential treatments that address the underlying drivers of heart disease.

Share on Social Networks: